Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression

Summary

This is an open-label proof-of-concept study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of SAGE-547 Injection in adult female participants diagnosed with severe postpartum depression (PPD).

Timeline

Start

2015-01-07

Primary completion

2015-06-05

Completion

2015-06-05

Drugs

Indications